Dyne Therapeutics Inc expected to post a loss of 71 cents a share - Earnings Preview

Dyne Therapeutics

25/10/2024 14:13

* Dyne Therapeutics Inc  DYN.OQ   DYN.O  is expected to show
no
change in quarterly revenue when it reports  results on October
28 (estimated) for the period ending September 30 2024
    * 
    * ​LSEG's mean analyst estimate for Dyne Therapeutics Inc is
for a
loss of 71 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Dyne
Therapeutics
Inc is $52.50​, above​ its last closing price of $31.10. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.68       -0.72      -0.70     Beat    2.5
 Mar. 31 2024  -0.80       -0.80      -0.81     Missed  -1.2
 Dec. 31 2023  -0.98       -0.92      -1.09     Missed  -18.9​
 Sep. 30 2023  -0.82       -0.83      -0.99     Missed  -18.9
 ​​Jun.        -0.79       -0.81      -1.08     Missed  -33.7
 30 2023                                                
 Mar. 31 2023  -0.76       -0.77      -0.78     Missed  -1.5​
 Dec. 31 2022  -0.80       -0.84      -0.74     Beat    12.4
 Sep. 30 2022  -0.91       -0.92      -0.80     Beat    13.2
 This summary was machine generated October 25 at 13:13 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)